Prevymis (letermovir)

pCPA File Number: 21052
Negotiation Status:
Concluded with an LOI
Indication(s):
Cytomegalovirus infection prophylaxis
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
SR0545-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: